EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting inflammation in atherosclerosis: overview, strategy and directions

Ron Waksman, Ilan Merdler, Brian C Case, Ori Waksman, Italo Porto

EuroIntervention · 2024-01 · 20 (1) · 32-44

DOI: 10.4244/eij-d-23-00606 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EuroIntervention, 2024-01. Verfasst von Ron Waksman und 4 weiteren Autor:innen. Beteiligte Einrichtung: MedStar Heart & Vascular Institute, MedStar Washington Hospital Center, MedStar Georgetown University Hospital, Washington, D.C., USA. Hauptthemen laut MEDLINE: Atherosclerosis, Cardiovascular Diseases. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a chronic condition characterised by the build-up of plaque in the inner lining of the blood vessels and it is the main underlying cause of cardiovascular disease. The development of atherosclerosis is associated with the accumulation of cholesterol and inflammation. Although effective therapies exist to lower low-density lipoprotein cholesterol (LDL-C) levels, some patients still experience cardiovascular events due to persistent inflammation, known as residual inflammatory risk (RIR). Researchers have conducted laboratory and animal studies to investigate the measurement and targeting of the inflammatory cascade associated with atherosclerosis, which have yielded promising results. In addition to guideline-directed lifestyle modifications and optimal medical therapy focusing on reducing LDL-C levels, pharmacological interventions targeting inflammation may provide further assistance in preventing future cardiac events. This review aims to explain the mechanisms of inflammation in atherosclerosis, identifies potential biomarkers, discusses available therapeutic options and their strengths and limitations, highlights future advancements, and summarises notable clinical studies. Finally, an evaluation and management algorithm for addressing RIR is presented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisCardiovascular DiseasesAnimalsHumansCholesterol, LDLInflammationCholesterolRisk Factors

Substanzen

Cholesterol, LDLCholesterol

Autor:innen und Institutionen

  • MedStar Heart & Vascular Institute, MedStar Washington Hospital Center, MedStar Georgetown University Hospital, Washington, D.C., USA.
  • Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino - Italian IRCCS Cardiology Network, Genoa, Italy.

Zitieren

APA

Waksman, R., Merdler, I., Case, B. C., Waksman, O., & Porto, I. (2024). Targeting inflammation in atherosclerosis: overview, strategy and directions. EuroIntervention, 20(1), 32-44. https://doi.org/10.4244/eij-d-23-00606

Vancouver

Waksman R, Merdler I, Case BC, Waksman O, Porto I. Targeting inflammation in atherosclerosis: overview, strategy and directions. EuroIntervention. 2024;20(1):32-44. doi:10.4244/eij-d-23-00606

BibTeX
@article{Waksman2024,
  author = {Waksman, Ron and Merdler, Ilan and Case, Brian C and Waksman, Ori and Porto, Italo},
  title = {Targeting inflammation in atherosclerosis: overview, strategy and directions},
  journal = {EuroIntervention},
  year = {2024},
  volume = {20},
  number = {1},
  pages = {32--44},
  doi = {10.4244/eij-d-23-00606}
}
Kostenlos starten →